Bitcoin Fuels $32M Peptide Market as Buyers Bypass Banks

The peptide market has seen a significant surge in cryptocurrency payments, particularly Bitcoin (BTC), in recent months. According to Chainalysis, gray-market peptide vendors received $32 million in cryptocurrency during the first quarter of 2026, a staggering 700% increase from the same period last year.

This trend is largely driven by the fact that banks and card networks often reject merchants selling unapproved compounds due to legal and regulatory risks. As a result, many suppliers are turning to Bitcoin as a payment tool for customers who may have previously avoided digital assets.

Zach, a 49-year-old marketing director, is one such customer who bought 20 vials of purported retatrutide from a Chinese seller for $240. The experimental weight-loss peptide is being developed by Eli Lilly & Co., and the vendor required Bitcoin payment through Coinbase Global Inc.

Experts warn that many products in this market lack reliable human safety and effectiveness data, labeling it as the 'wild, wild west'. Lee Rosebush, chair of the American Academy of Peptide Medicine, suggests that clearer rules could reduce research-only suppliers while improving access to tested medicines.